Showing results (1241-1250 of 1,426) with videos related to
Sort By:
Pageof 143
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapySeok Yun Kang, Jae Ho Han, Kwang Jae Lee, et al.Psychiatry Research|March 19, 2013
Lack of association between DISC1 polymorphisms and risk of schizophrenia in a Korean populationJoon Seol Bae, Jason Yongha Kim, Byung-Lae Park, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|July 21, 2020
Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic ShockKi Hong Choi, Jeong Hoon Yang, David Hong, et al.International Journal of Cardiology|April 1, 2018
Effects of chronic kidney disease on clinical outcomes in patients with peripheral artery disease undergoing endovascular treatment: Analysis from the K-VIS ELLA registryHyung Oh Kim, Jae-Min Kim, Jong Shin Woo, et al.Scientific Reports|May 1, 2019
The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: A multicenter prospective registry-based observational studySeung Mok Ryoo, Kap Su Han, Shin Ahn, et al.Scientific Reports|July 6, 2019
Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarctionDavid Hong, Ki Hong Choi, Young Bin Song, et al.Lung Cancer (Amsterdam, Netherlands)|June 30, 2009
Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapySeong Hyun Jeong, Jae Ho Jung, Jae Ho Han, et al.Brain Research|May 29, 2012
Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean populationJoon Seol Bae, Charisse Flerida A Pasaje, Byung-Lae Park, et al.The Lancet. Oncology|December 3, 2014
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trialSung Hoon Noh, Sook Ryun Park, Han-Kwang Yang, et al.International Journal of Cardiology|July 12, 2016
Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysisA Young Lim, Taek Kyu Park, Sung Woo Cho, et al.Pageof 143